JP2015522077A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015522077A5 JP2015522077A5 JP2015521792A JP2015521792A JP2015522077A5 JP 2015522077 A5 JP2015522077 A5 JP 2015522077A5 JP 2015521792 A JP2015521792 A JP 2015521792A JP 2015521792 A JP2015521792 A JP 2015521792A JP 2015522077 A5 JP2015522077 A5 JP 2015522077A5
- Authority
- JP
- Japan
- Prior art keywords
- amount
- fampridine
- laquinimod
- pharmaceutical composition
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261670758P | 2012-07-12 | 2012-07-12 | |
| US61/670,758 | 2012-07-12 | ||
| PCT/US2013/050001 WO2014011827A1 (en) | 2012-07-12 | 2013-07-11 | Treatment of multiple sclerosis with combination of laquinimod and fampridine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015522077A JP2015522077A (ja) | 2015-08-03 |
| JP2015522077A5 true JP2015522077A5 (enExample) | 2016-09-01 |
Family
ID=49914160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015521792A Pending JP2015522077A (ja) | 2012-07-12 | 2013-07-11 | ラキニモドおよびファムプリジンの組合せによる多発性硬化症の治療 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20140017226A1 (enExample) |
| EP (1) | EP2872217A4 (enExample) |
| JP (1) | JP2015522077A (enExample) |
| KR (1) | KR20150038072A (enExample) |
| CN (1) | CN104582793A (enExample) |
| AR (1) | AR091724A1 (enExample) |
| AU (1) | AU2013290181A1 (enExample) |
| BR (1) | BR112015000616A2 (enExample) |
| CA (1) | CA2873229A1 (enExample) |
| EA (1) | EA201590191A1 (enExample) |
| HK (1) | HK1209672A1 (enExample) |
| IL (1) | IL236230A0 (enExample) |
| MX (1) | MX2015000485A (enExample) |
| TW (1) | TW201408300A (enExample) |
| UY (1) | UY34896A (enExample) |
| WO (1) | WO2014011827A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106063787A (zh) | 2012-02-03 | 2016-11-02 | 泰华制药工业有限公司 | 拉喹莫德用于治疗一线抗TNFα疗法失败的克罗恩氏病患者的用途 |
| KR20140138725A (ko) | 2012-02-16 | 2014-12-04 | 테바 파마슈티컬 인더스트리즈 리미티드 | N-에틸-n-페닐-1,2-디하이드로-4,5-디-하이드록시-1-메틸-2-옥소-3-퀴놀린카복사미드, 그의 제조 및 용도 |
| TW201410244A (zh) | 2012-08-13 | 2014-03-16 | Teva Pharma | 用於治療ｇａｂａ媒介之疾病之拉喹莫德（ｌａｑｕｉｎｉｍｏｄ） |
| HK1212936A1 (zh) | 2012-11-07 | 2016-06-24 | Teva Pharmaceutical Industries Ltd. | 拉喹莫德胺盐 |
| NZ630427A (en) | 2013-03-14 | 2017-06-30 | Teva Pharma | Crystals of laquinimod sodium and improved process for the manufacture thereof |
| UY36099A (es) | 2014-04-29 | 2016-02-29 | Teva Pharma | Laquinimod para el tratamiento de pacientes con esclerosis múltiple remitente recurrente (rrms) con un alto grado de discapacidad |
| GB2540163A (en) * | 2015-07-07 | 2017-01-11 | Univ London Queen Mary | Combination therapy for treating multiple sclerosis |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9726339D0 (en) * | 1997-12-13 | 1998-02-11 | Zeneca Ltd | Human-derived tissue-specific potassium channel |
| US20090082471A1 (en) * | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched fingolimod |
| ES2329327B1 (es) * | 2008-03-19 | 2010-09-17 | Proyecto De Biomedicina Cima, S.L. | Combinaciones sinergicas de 5'-metiltioadenosina. |
| AU2009291781A1 (en) * | 2008-09-10 | 2010-03-18 | Acorda Therapeutics, Inc. | Methods of using sustained release aminopyridine compositions |
| CN107308162A (zh) * | 2009-06-19 | 2017-11-03 | 泰华制药工业有限公司 | 利用拉喹莫德治疗多发性硬化 |
| SG11201401330YA (en) * | 2011-10-12 | 2014-05-29 | Teva Pharma | Treatment of multiple sclerosis with combination of laquinimod and fingolimod |
-
2013
- 2013-07-09 UY UY0001034896A patent/UY34896A/es not_active Application Discontinuation
- 2013-07-10 TW TW102124792A patent/TW201408300A/zh unknown
- 2013-07-10 AR ARP130102454 patent/AR091724A1/es unknown
- 2013-07-11 WO PCT/US2013/050001 patent/WO2014011827A1/en not_active Ceased
- 2013-07-11 CN CN201380037036.0A patent/CN104582793A/zh active Pending
- 2013-07-11 AU AU2013290181A patent/AU2013290181A1/en not_active Abandoned
- 2013-07-11 KR KR1020157003858A patent/KR20150038072A/ko not_active Withdrawn
- 2013-07-11 EA EA201590191A patent/EA201590191A1/ru unknown
- 2013-07-11 BR BR112015000616A patent/BR112015000616A2/pt not_active IP Right Cessation
- 2013-07-11 CA CA2873229A patent/CA2873229A1/en not_active Abandoned
- 2013-07-11 HK HK15110240.0A patent/HK1209672A1/xx unknown
- 2013-07-11 JP JP2015521792A patent/JP2015522077A/ja active Pending
- 2013-07-11 EP EP13816075.9A patent/EP2872217A4/en not_active Withdrawn
- 2013-07-11 MX MX2015000485A patent/MX2015000485A/es unknown
- 2013-07-11 US US13/939,306 patent/US20140017226A1/en not_active Abandoned
-
2014
- 2014-12-14 IL IL236230A patent/IL236230A0/en unknown
-
2016
- 2016-04-21 US US15/135,280 patent/US20160235735A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7650929B2 (ja) | 成人における焦点てんかんの処置のための合成経皮的カンナビジオール | |
| JP2015512406A5 (enExample) | ||
| JP2015522077A5 (enExample) | ||
| JP2010518122A5 (enExample) | ||
| FI3504187T3 (fi) | Pridopidiinin käyttö toiminnallisen heikkenemisen hoitoa varten | |
| HK1206246A1 (en) | Use of high dose laquinimod for treating multiple sclerosis | |
| JP2017510607A5 (enExample) | ||
| JP2017510607A (ja) | Ｓ１ｐ調節剤即時放出投与レジメン | |
| JP2016510343A5 (enExample) | ||
| JP2020500864A5 (enExample) | ||
| JP2019023195A (ja) | Ｌ−４−クロロキヌレニンの剤形及び治療的使用 | |
| KR20170128633A (ko) | 탈수초성 질환 및 다른 신경계 질환을 앓는 환자에서 신경-인지 및/또는 신경-정신 손상을 개선하기 위한 4-아미노피리딘의 용도 | |
| EA028060B1 (ru) | Комбинированная терапия бокового амиотрофического склероза | |
| JP2016505050A5 (enExample) | ||
| US20050282879A1 (en) | Methods and composition for treatment of migraine and symptoms thereof | |
| JP6885649B2 (ja) | 統合失調症の治療のためのイロペリドン | |
| Kim et al. | A randomized, double-blind, multicenter, phase III study to evaluate the efficacy and safety of fimasartan/amlodipine combined therapy versus fimasartan monotherapy in patients with essential hypertension unresponsive to fimasartan monotherapy | |
| JPH03170475A (ja) | 抑うつ症治療剤 | |
| RU2006139819A (ru) | Применение симетикона для предрасположенных к запорам пациентов | |
| US20200360303A1 (en) | Method for treating hyperhidrosis | |
| KR101978459B1 (ko) | 조루증 치료용 약학 조성물 및 조루증 치료 방법 | |
| JP2015515971A5 (enExample) | ||
| FI3359572T3 (fi) | Menetelmä multippeliskleroosin hoitamiseksi | |
| JP2016533323A5 (enExample) | ||
| EP2767287B1 (en) | Agent for preventing or treating htlv-i associated myelopathy |